Exane Derivatives’s Ball Corp BALL Stock Holding History

Exane Derivatives’s Portfolio BALL Stock Details BALL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,502	Closed	-$405K	–	799
2022 Q1	$405K	Sell	4,502 -1,008	-18%	-$91.7K	0.11%	215
2021 Q4	$530K	Sell	5,510 -3,818	-41%	-$353K	0.13%	166
2021 Q3	$839K	Buy	9,328 +9,326	+466,300%	+$827K	0.2%	106
2021 Q2	$169	Buy	+2	New	+$173	﹤0.01%	1019
2021 Q1	–	Sell	-36	Closed	-$3.35K	–	919
2020 Q4	$3.35K	Hold	36	–	–	﹤0.01%	584
2020 Q3	$2.99K	Hold	36	–	–	﹤0.01%	541
2020 Q2	$2.5K	Hold	36	–	–	﹤0.01%	489
2020 Q1	$2.33K	Hold	36	–	–	﹤0.01%	490
2019 Q4	$2.46K	Hold	36	–	–	﹤0.01%	483
2019 Q3	$2.62K	Hold	36	–	–	﹤0.01%	473
2019 Q2	$2.52K	Buy	+36	New	+$2.24K	﹤0.01%	497
2019 Q1	–	Sell	-36	Closed	-$1.66K	–	670
2018 Q4	$1.66K	Buy	+36	New	+$1.68K	﹤0.01%	536
2017 Q4	–	Sell	-2	Closed	-$83	–	611
2017 Q3	$83	Hold	2	–	–	﹤0.01%	516
2017 Q2	$84	Hold	2	–	–	﹤0.01%	574
2017 Q1	$74	Hold	2	–	–	﹤0.01%	504
2016 Q4	$75	Hold	2	–	–	﹤0.01%	558
2016 Q3	$82	Buy	+2	New	+$76	﹤0.01%	543

Other funds holding BALL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Exane Derivatives's BALL Position: Q2 2022 in Review

Exane Derivatives sold out of Ball Corp (BALL) in Q2 2022, closing a stake of 4,502 shares — an estimated $405K sold.

Exane Derivatives first reported a position in BALL in Q3 2016 and held it in 17 quarters. The position peaked at $839K in Q3 2021. 691 funds tracked by Wall St. Rank hold BALL as of Q2 2022.

Exane Derivatives reported no remaining Ball Corp position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 4,502 Ball Corp shares in Q2 2022, an estimated $405K.
Exane Derivatives first reported a position in Ball Corp in Q3 2016 and held it in 17 quarters.
Exane Derivatives's Ball Corp position peaked at $839K in Q3 2021.
691 funds tracked by Wall St. Rank held Ball Corp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.